Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Clinical Nutrition ESPEN|May 23, 2017
Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxelSamantha J Cushen, Derek G Power, Kevin P Murphy, et al.
The American Journal of Hospice & Palliative Care|January 13, 2021
A Multicenter Retrospective Review of Systemic Anti-Cancer Treatment and Palliative Care Provided to Solid Tumor Oncology Patients in the 12 Weeks Preceding Death in IrelandVictoria Mallett, Anna Linehan, Orla Burke, et al.
JCO Global Oncology|February 4, 2026
National Trends in Early-Onset Colorectal Cancer: Incidence and Challenges in the Republic of IrelandMary O'Reilly, Aleksandar Krstic, Luis F Iglesias-Martinez, et al.
Cancer Medicine|July 22, 2014
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countriesCamillo Porta, Antonin Levy, Robert Hawkins, et al.
JCO Clinical Cancer Informatics|April 13, 2023
The Impact of a National Cyberattack Affecting Clinical Trials: The Cancer Trials Ireland ExperienceHarry Harvey, Hailey Carroll, Verena Murphy, et al.
BMC Cancer|August 31, 2018
Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumoursNicola J Lawrence, Howard Chan, Guy Toner, et al.
Clinical Colorectal Cancer|May 3, 2017
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative StudyYoung Soo Rho, Marine Gilabert, Karol Polom, et al.
International Journal of Molecular Sciences|February 7, 2020
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma PatientsSandra Roche, Fiona O'Neill, Jean Murphy, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2025
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trialAdrien Rousseau, Maryam Karimi, Stefan Michiels, et al.
The Lancet. Oncology|July 24, 2017
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 studyMichael J Overman, Ray McDermott, Joseph L Leach, et al.
Pageof 10